Safety, efficacy, and cost analysis of thymoglobulin induction therapy with intermittent dosing based on CD3+ lymphocyte counts in kidney and kidney-pancreas transplant recipients (Q44002438)
Jump to navigation
Jump to search
scientific article published in May 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety, efficacy, and cost analysis of thymoglobulin induction therapy with intermittent dosing based on CD3+ lymphocyte counts in kidney and kidney-pancreas transplant recipients |
scientific article published in May 2002 |
Statements
1 reference
Safety, efficacy, and cost analysis of thymoglobulin induction therapy with intermittent dosing based on CD3+ lymphocyte counts in kidney and kidney-pancreas transplant recipients (English)
1 reference
E Steve Woodle
1 reference
V Ram Peddi
1 reference
Margaret Bryant
1 reference
Prabir Roy-Chaudhury
1 reference
M Roy First
1 reference
1 May 2002
1 reference
1 reference
73
1 reference
9
1 reference
1514-1518
1 reference
Identifiers
1 reference
1 reference